Notably, a C1858T SNP, corresponding to an arginine (R) to tryptophan (W) mutation at position 620 in the P1 proline-rich motif of PTPN22 leads to reduced binding to C-terminal Src Kinase and increased risk of several autoimmune diseases (12, 13). This evidence concerns the gene PTPN22 and autoimmune disease.